About the Authors
- Mara Colombo
-
* E-mail: mara.colombo@istitutotumori.mi.it
Affiliation Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
- Giovanna De Vecchi
-
Affiliation Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
- Laura Caleca
-
Affiliation Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
- Claudia Foglia
-
Affiliation Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
- Carla B. Ripamonti
-
Affiliation Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
- Filomena Ficarazzi
-
Affiliations Cogentech, Consortium for Genomic Technologies, IFOM-IEO Campus, Milano, Italy, IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milano, Italy
- Monica Barile
-
Affiliation Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milano, Italy
- Liliana Varesco
-
Affiliation Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS San Martino IST- Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
- Bernard Peissel
-
Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
- Siranoush Manoukian
-
Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
- Paolo Radice
-
Affiliations Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy, IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milano, Italy
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Performed the in silico analysis: MC. Established lymphoblastoid cell lines: CF. Perfomed genetic counselling: CBR MB LV BP SM. Performed BRCA gene mutation screening: FF. Supervised the study: PR. Conceived and designed the experiments: MC GDV LC. Performed the experiments: MC GDV LC. Analyzed the data: MC PR. Wrote the paper: MC LC PR.